A new Lyme vaccine is on the horizon — and doctors on Long Island say it could be a game changer, if the public is willing to ...

Valneva SE, (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced an exclusive agreement with CSL Seqirus, one of the world’s largest influenza vaccine companies, for the ...

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Board of Directors were approved by the shareholders at its ...

Scotland's largest vaccine producer, Valneva Scotland Ltd, based in Livingston, has been awarded a Gold Award for health and ...

A new Lyme disease vaccine, VLA15, is currently being tested and the manufacturers could ask the FDA for authorization as ...

Scotland’s largest vaccine producer Valneva has renewed its contract with Glasgow-based communications consultancy, ...

The FDA approval of Vimkunya has given the chikungunya vaccine’s owner, Bavarian Nordic, an extra financial windfall. | The ...

UK's medicine regulator said on Monday it has temporarily restricted the use of French vaccine maker Valneva's shot to protect against chikungunya, a virus transmitted by mosquitoes, in people ...

Valneva’s vaccine was found to be well-tolerated across all doses in children, without any safety concerns observed. Credit: Valneva. Valneva has reported encouraging six-month safety and antibody ...

Valneva Investor and Media Contacts Laetitia Bachelot-Fontaine VP Global Communications & European Investor Relations M +33 (0)6 4516 7099 laetitia.bachelot-fontaine@valneva.com Joshua Drumm, Ph.D. VP ...

Saint-Herblain (France), June 5, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced positive six-month antibody persistence and safety data for ...